EU says decision on J&J COVID-19 vaccine booster dose ‘within weeks’

Nov 22 (Reuters) – The European Union’s drug regulator said on Monday it was evaluating data on booster doses of the COVID-19 vaccine by Johnson & Johnson and a decision could come “within weeks” under a speedy review.

The application is for use of a booster dose of the vaccine, COVID-19 Vaccine Janssen, to be given at least two months after the first dose to people aged 18 years and older, the European Medicines Agency (EMA) said.

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Shinjini Ganguli)

PHOTO – Exterior view of the pharmaceutical company Janssen in Leiden, The Netherlands. EPA-EFE/SEM VAN DER WAL

Discover more from The Dispatch

Subscribe now to keep reading and get access to the full archive.

Continue reading

Verified by MonsterInsights